Laurent Chambonneau

711 total citations
15 papers, 546 citations indexed

About

Laurent Chambonneau is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Endocrinology. According to data from OpenAlex, Laurent Chambonneau has authored 15 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 11 papers in Infectious Diseases and 3 papers in Endocrinology. Recurrent topics in Laurent Chambonneau's work include Mosquito-borne diseases and control (13 papers), Viral Infections and Vectors (10 papers) and Malaria Research and Control (9 papers). Laurent Chambonneau is often cited by papers focused on Mosquito-borne diseases and control (13 papers), Viral Infections and Vectors (10 papers) and Malaria Research and Control (9 papers). Laurent Chambonneau collaborates with scholars based in France, United States and Thailand. Laurent Chambonneau's co-authors include Jean Lang, Rémi Forrat, Bruno Guy, Pornthep Chanthavanich, Krisana Pengsaa, Sutee Yoksan, Arunee Sabchareon, Violette Sanchez, Rafaele Dumas and Fernando Noriega and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

Laurent Chambonneau

15 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Chambonneau France 11 478 437 51 25 23 15 546
Timothy Burgess United States 11 579 1.2× 509 1.2× 52 1.0× 19 0.8× 23 1.0× 15 652
Oswaldo G. Cruz Brazil 11 423 0.9× 348 0.8× 51 1.0× 11 0.4× 19 0.8× 13 542
John Mark Velasco Thailand 10 291 0.6× 287 0.7× 78 1.5× 18 0.7× 10 0.4× 31 437
Jyh-Hsiung Huang Taiwan 9 365 0.8× 333 0.8× 42 0.8× 10 0.4× 26 1.1× 10 439
Susana Widjaja United States 14 563 1.2× 458 1.0× 44 0.9× 10 0.4× 9 0.4× 25 634
Diane van der Vliet France 10 143 0.3× 149 0.3× 57 1.1× 23 0.9× 12 0.5× 17 253
Cuitláhuac Ruíz-Matus Mexico 11 151 0.3× 146 0.3× 79 1.5× 38 1.5× 16 0.7× 24 298
Daría Elena Camacho Venezuela 9 340 0.7× 270 0.6× 37 0.7× 14 0.6× 11 0.5× 18 399
Ghazi A. Jamjoom Saudi Arabia 7 128 0.3× 200 0.5× 43 0.8× 8 0.3× 14 0.6× 11 344
Kavita Diddi India 5 190 0.4× 177 0.4× 56 1.1× 9 0.4× 5 0.2× 5 317

Countries citing papers authored by Laurent Chambonneau

Since Specialization
Citations

This map shows the geographic impact of Laurent Chambonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Chambonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Chambonneau more than expected).

Fields of papers citing papers by Laurent Chambonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Chambonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Chambonneau. The network helps show where Laurent Chambonneau may publish in the future.

Co-authorship network of co-authors of Laurent Chambonneau

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Chambonneau. A scholar is included among the top collaborators of Laurent Chambonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Chambonneau. Laurent Chambonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Ying, Brian D. Williamson, Zoe Moodie, et al.. (2021). Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials. The Journal of Infectious Diseases. 225(2). 332–340. 4 indexed citations
2.
Huang, Ying, Zoe Moodie, Michal Juraska, et al.. (2020). Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 115(7). 750–763. 3 indexed citations
3.
Carpp, Lindsay N., Youyi Fong, Matthew Bonaparte, et al.. (2020). Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America. PLoS ONE. 15(6). e0234236–e0234236. 9 indexed citations
4.
Gilbert, Peter B., Ying Huang, Michal Juraska, et al.. (2019). Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response. American Journal of Tropical Medicine and Hygiene. 101(1). 164–179. 10 indexed citations
5.
Pasin, Chloé, M. Elizabeth Halloran, Peter B. Gilbert, et al.. (2018). Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease. PLoS ONE. 13(12). e0207878–e0207878. 5 indexed citations
6.
Moodie, Zoe, Michal Juraska, Ying Huang, et al.. (2017). Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America. The Journal of Infectious Diseases. 217(5). 742–753. 74 indexed citations
7.
Coudeville, Laurent, et al.. (2016). Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America. The Journal of Infectious Diseases. 214(7). 994–1000. 42 indexed citations
8.
Torresi, Joseph, Leon Heron, Ming Qiao, et al.. (2015). Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study. Vaccine. 33(39). 5127–5134. 19 indexed citations
9.
Guy, Bruno, Nolwenn Nougarede, Violette Sanchez, et al.. (2008). Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine. 26(45). 5712–5721. 117 indexed citations
10.
Pengsaa, Krisana, Kriengsak Limkittikul, Christine Luxemburger, et al.. (2008). AGE-SPECIFIC PREVALENCE OF DENGUE ANTIBODIES IN BANGKOK INFANTS AND CHILDREN. The Pediatric Infectious Disease Journal. 27(5). 461–463. 14 indexed citations
11.
Sanchez, Violette, Brian Tomlinson, Paul K.S. Chan, et al.. (2006). Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). Vaccine. 24(23). 4914–4926. 52 indexed citations
12.
Pengsaa, Krisana, Christine Luxemburger, Arunee Sabchareon, et al.. (2006). Dengue Virus Infections in the First 2 Years of Life and the Kinetics of Transplacentally Transferred Dengue Neutralizing Antibodies in Thai Children. The Journal of Infectious Diseases. 194(11). 1570–1576. 44 indexed citations
13.
Overbosch, D., et al.. (2006). Combined Typhoid Fever and Hepatitis A Vaccine: Comparison of Immunogenicity and Safety to Concomitant Monovalent Vaccine over 3 Years. Journal of Travel Medicine. 12(6). 319–326. 27 indexed citations
14.
Loebermann, Micha, Herwig Kollaritsch, Pamela Rendi‐Wagner, et al.. (2004). A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults. Clinical Therapeutics. 26(7). 1084–1091. 11 indexed citations
15.
Sabchareon, Arunee, Jean Lang, Pornthep Chanthavanich, et al.. (2004). Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. The Pediatric Infectious Disease Journal. 23(2). 99–109. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026